A new study presented recently at the 2017 Annual Meeting of the American College of Rheumatology identifies four factors that may predict which rheumatoid arthritis (RA) patients might successfully taper the dose of their biologic medication.
Although biologics are highly effective in controlling RA and its symptoms, patients in some cases prefer not to use them. Past studies have shown that it is possible to taper and even stop the medication in certain patients who are in remission once they have been successfully treated with one of these drugs.
Continue reading Research Identifies Which RA Patients May Successfully Reduce Their Biologics
Biologic drugs make it possible for many people with inflammatory types of arthritis, such as rheumatoid arthritis (RA), to achieve low disease activity or remission. But because of the drugs’ cost and the potential for serious side effects, many patients don’t want to stay on them indefinitely, so researchers have been looking at whether it’s possible to taper or stop them. A new study, published recently in Arthritis & Rheumatology, is adding to the growing body of research on the topic.
Continue reading Study: Risk of Rheumatoid Arthritis Flare Triples in People Who Stop Anti-TNFs